Multiple pathogenic roles of microvasculature in inflammatory bowel disease: A jack of all trades

American Journal of Pathology

Volumn 172, Issue 6, 2008, Pages 1457-1466

  Deban, Livija ^a   Correale, Carmen ^a   Vetrano, Stefania ^a   Malesci, Alberto ^a,b   Danese, Silvio ^a  

^a HUMANITAS CLINICAL AND RESEARCH CENTER   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CYTOKINE; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN A;

ANGIOGENESIS; BLOOD CLOTTING; CELL ACTIVATION; CELL INTERACTION; CHRONIC INFLAMMATION; CROHN DISEASE; CYTOKINE PRODUCTION; ENDOTHELIUM CELL; HUMAN; HYPERCOAGULABILITY; IMMUNOMODULATION; INNATE IMMUNITY; MICROVASCULATURE; NEOVASCULARIZATION (PATHOLOGY); NONHUMAN; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE; ULCERATIVE COLITIS; VASCULAR ENDOTHELIUM;

EID: 44849118823     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.2353/ajpath.2008.070593     Document Type: Review

References (105)

1. Fiocchi C: Inflammatory bowel disease: etiology and pathogenesis. Gastroenterology 1998, 115:182-205
2. Fiocchi C: Inflammatory bowel disease: dogmas and heresies. Dig Liver Dis 2002, 34:306-311
3. Fiocchi C: Intestinal inflammation: a complex interplay of immune and nonimmune cell interactions. Am J Physiol 1997, 273:G769-G775
4. Danese S, Dejana E, Fiocchi C: Immune regulation by microvascular endothelial cells: directing innate and adaptive immunity, coagulation, and inflammation. J Immunol 2007, 178:6017-6022
5. Granger DN, Kubes P: The microcirculation and inflammation: modulation of leukocyte-endothelial cell adhesion. J Leukoc Biol 1994, 55:662-675
6. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, Pober JS, Wick TM, Konkle BA, Schwartz BS, Barnathan ES, McCrae KR, Hug BA, Schmidt AM, Stern DM: Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood 1998, 91:3527-3561
7. Ades EW, Candal FJ, Swerlick RA, George VG, Summers S, Bosse DC, Lawley TJ: HMEC-1: establishment of an immortalized human microvascular endothelial cell line. J Invest Dermatol 1992, 99:683-690
8. Binion DG, West GA, Ina K, Ziats NP, Emancipator SN, Fiocchi C: Enhanced leukocyte binding by intestinal microvascular endothelial cells in inflammatory bowel disease. Gastroenterology 1997, 112:1895-1907
9. Kvietys PR, Granger DN: Endothelial cell monolayers as a tool for studying microvascular pathophysiology. Am J Physiol 1997, 273:G1189-G1199
10. Aird WC, Edelberg JM, Weiler-Guettler H, Simmons WW, Smith TW, Rosenberg RD: Vascular bed-specific expression of an endothelial cell gene is programmed by the tissue microenvironment. J Cell Biol 1997, 138:1117-1124
11. Granger DN: Cell adhesion and migration. II. Leukocyte-endothelial cell adhesion in the digestive system. Am J Physiol 1997, 273:G982-G986
12. Hatoum OA, Miura H, Binion DG: The vascular contribution in the pathogenesis of inflammatory bowel disease. Am J Physiol Heart Circ Physiol 2003, 285:H1791-H1796
13. Briskin M, Winsor-Hines D, Shyjan A, Cochran N, Bloom S, Wilson J, McEvoy LM, Butcher EC, Kassam N, Mackay CR, Newman W, Ringler DJ: Human mucosal addressin cell adhesion molecule-1 is preferentially expressed in intestinal tract and associated lymphoid tissue. Am J Pathol 1997, 151:97-110
14. Salmi M, Granfors K, MacDermott R, Jalkanen S: Aberrant binding of lamina propria lymphocytes to vascular endothelium in inflammatory bowel diseases. Gastroenterology 1994, 106:596-605
15. Burgio VL, Fais S, Boirivant M, Perrone A, Pallone F: Peripheral monocyte and naive T-cell recruitment and activation in Crohn's disease. Gastroenterology 1995, 109:1029-1038
16. Binion DG, West GA, Volk EE, Drazba JA, Ziats NP, Petras RE, Fiocchi C: Acquired increase in leucocyte binding by intestinal microvascular endothelium in inflammatory bowel disease. Lancet 1998, 352:1742-1746
17. Krieglstein CF, Cerwinka WH, Laroux FS, Salter JW, Russell JM, Schuermann G, Grisham MB, Ross CR, Granger DN: Regulation of murine intestinal inflammation by reactive metabolites of oxygen and nitrogen: divergent roles of superoxide and nitric oxide. J Exp Med 2001, 194:1207-1218
18. Kubes P, McCafferty DM: Nitric oxide and intestinal inflammation. Am J Med 2000, 109:150-158
19. Binion DG, Rafiee P, Ramanujam KS, Fu S, Fisher PJ, Rivera MT, Johnson CP, Otterson MF, Telford GL, Wilson KT: Deficient iNOS in inflammatory bowel disease intestinal microvascular endothelial cells results in increased leukocyte adhesion. Free Radic Biol Med 2000, 29:881-888
20. Binion DG, Fu S, Ramanujam KS, Chai YC, Dweik RA, Drazba JA, Wade JG, Ziats NP, Erzurum SC, Wilson KT: iNOS expression in human intestinal microvascular endothelial cells inhibits leukocyte adhesion. Am J Physiol 1998, 275:G592-G603
21. Horowitz S, Binion DG, Nelson V, Kanaa Y, Javadi P, Lazarova Z, Andrekopoulos C, Kalyanaraman B, Otterson MF, Rafiee P: Increased arginase activity and endothelial dysfunction in human inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2007, 292:G1323-G1336
22. Muehlhoefer A, Saubermann LJ, Gu X, Luedtke-Heckenkamp K, Xavier R, Blumberg RS, Podolsky DK, MacDermott RP, Reinecker HC: Fractalkine is an epithelial and endothelial cell-derived chemoattractant for intraepithelial lymphocytes in the small intestinal mucosa. J Immunol 2000, 164:3368-3376
23. Sans M, Danese S, de la Motte C, de Souza HS, Rivera-Reyes BM, West GA, Phillips M, Katz JA, Fiocchi C: Enhanced recruitment of CX3CR1+ T cells by mucosal endothelial cell-derived fractalkine in inflammatory bowel disease. Gastroenterology 2007, 132:139-153
24. Danese S, Sgambato A, Papa A, Scaldaferri F, Pola R, Sans M, Lovecchio M, Gasbarrini G, Cittadini A, Gasbarrini A: Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease. Am J Gastroenterol 2005, 100:886-895
25. Vowinkel T, Anthoni C, Wood KC, Stokes KY, Russell J, Gray L, Bharwani S, Senninger N, Alexander JS, Krieglstein CF, Grisham MB, Granger DN: CD40-CD40 ligand mediates the recruitment of leukocytes and platelets in the inflamed murine colon. Gastroenterology 2007, 132:955-965
26. Iwasaki A, Medzhitov R: Toll-like receptor control of the adaptive immune responses. Nat Immunol 2004, 5:987-995
27. Noble C, Nimmo E, Gaya D, Russell RK, Satsangi J: Novel susceptibility genes in inflammatory bowel disease. World J Gastroenterol 2006, 12:1991-1999
28. Haraldsen G, Kvale D, Lien B, Farstad IN, Brandtzaeg P: Cytokine-regulated expression of E-selectin, intercellular adhesion molecule-1 (ICAM-1), and vascular cell adhesion molecule-1 (VCAM-1) in human microvascular endothelial cells. J Immunol 1996, 156:2558-2565
29. Ogawa H, Rafiee P, Heidemann J, Fisher PJ, Johnson NA, Otterson MF, Kalyanaraman B, Pritchard KA Jr, Binion DG: Mechanisms of endotoxin tolerance in human intestinal microvascular endothelial cells. J Immunol 2003, 170:5956-5964
30. Gewirtz AT: Flag in the crossroads: flagellin modulates innate and adaptive immunity. Curr Opin Gastroenterol 2006, 22:8-12
31. Maaser C, Heidemann J, von Eiff C, Lugering A, Spahn TW, Binion DG, Domschke W, Lugering N, Kucharzik T: Human intestinal microvascular endothelial cells express Toll-like receptor 5: a binding partner for bacterial flagellin. J Immunol 2004, 172:5056-5062
32. Nilsen EM, Johansen FE, Jahnsen FL, Lundin KE, Scholz T, Brandtzaeg P, Haraldsen G: Cytokine profiles of cultured microvascular endothelial cells from the human intestine. Gut 1998, 42:635-642
33. Saadi S, Wrenshall LE, Platt JL: Regional manifestations and control of the immune system. FASEB J 2002, 16:849-856
34. Dhillon AP, Anthony A, Sim R, Wakefield AJ, Sankey EA, Hudson M, Allison MC, Pounder RE: Mucosal capillary thrombi in rectal biopsies. Histopathology 1992, 21:127-133
35. Danese S, de la Motte C, Fiocchi C: Platelets in Inflammatory bowel disease: clinical, pathological and therapeutical implications. Am J Gastroenterol 2004, 99:938-945
36. Collins CE, Rampton DS, Rogers J, Williams NS: Platelet aggregation and neutrophil sequestration in the mesenteric circulation in inflammatory bowel disease. Eur J Gastroenterol Hepatol 1997, 9:1213-1217
37. Fagerstam JP, Whiss PA: Higher platelet P-selectin in male patients with inflammatory bowel disease compared to healthy males. World J Gastroenterol 2006, 12:1270-1272
38. Andoh A, Yoshida T, Yagi Y, Bamba S, Hata K, Tsujikawa T, Kitoh K, Sasaki M, Fujiyama Y: Increased aggregation response of platelets in patients with inflammatory bowel disease. J Gastroenterol 2006, 41:47-54
39. Danese S, Katz JA, Saibeni S, Papa A, Gasbarrini A, Vecchi M, Fiocchi C: Activated platelets are the source of elevated levels of soluble CD40 ligand in the circulation of inflammatory bowel disease patients. Gut 2003, 52:1435-1441
40. Danese S, de la Motte C, Sturm A, Vogel JD, West GA, Strong SA, Katz JA, Fiocchi C: Platelets trigger a CD40-dependent inflammatory response in the microvasculature of inflammatory bowel disease patients. Gastroenterology 2003, 124:1249-1264
41. Power CA, Clemetson JM, Clemetson KJ, Wells TN: Chemokine and chemokine receptor mRNA expression in human platelets. Cytokine 1995, 7:479-482
42. Devergne O, Marfaing-Koka A, Schall TJ, Leger-Ravet MB, Sadick M, Peuchmaur M, Crevon MC, Kim KJ, Schall TT, Kim T: Production of the RANTES chemokine in delayed-type hypersensitivity reactions: involvement of macrophages and endothelial cells. J Exp Med 1994, 179:1689-1694
43. Russell J, Cooper D, Tailor A, Stokes KY, Granger DN: Low venular shear rates promote leukocyte-dependent recruitment of adherent platelets. Am J Physiol Gastrointest Liver Physiol 2003, 284:G123-G129
44. Vowinkel T, Mori M, Overell K, Stokes KY, Russell J, Krieglstein CF, Granger DN: Platelet-leukocyte (WBC) Interactions in experimental colitis are mediated by CD40L and ICAM-1. Gastroenterology 2004, 126:A-21
45. Irving PM, Pasi KJ, Rampton DS: Thrombosis and inflammatory bowel disease. Clin Gastroenterol Hepatol 2005, 3:617-628
46. Mori M, Salter JW, Vowinkel T, Krieglstein CF, Stokes KY, Granger DN: Molecular determinants of the prothrombogenic phenotype assumed by inflamed colonic venules. Am J Physiol Gastrointest Liver Physiol 2005, 288:G920-G926
47. Vowinkel T, Wood KC, Stokes KY, Russell J, Tailor A, Anthoni C, Senninger N, Krieglstein CF, Granger DN: Mechanisms of platelet and leukocyte recruitment in experimental colitis. Am J Physiol Gastrointest Liver Physiol 2007, 293:G1054-G1060
48. Suzuki K, Sugimura K, Hasegawa K, Yoshida K, Suzuki A, Ishizuka K, Ohtsuka K, Honma T, Narisawa R, Asakura H: Activated platelets in ulcerative colitis enhance the production of reactive oxygen species by polymorphonuclear leukocytes. Scand J Gastroenterol 2001, 36:1301-1306
49. Talbot RW, Heppell J, Dozois RR, Beart RW Jr: Vascular complications of inflammatory bowel disease. Mayo Clin Proc 1986, 61:140-145
50. Schapira M, Henrion J, Ravoet C, Maisin JM, Ghilain JM, De Maeght S, Heller F: Thromboembolism in inflammatory bowel disease. Acta Gastroenterol Belg 1999, 62:182-186
51. Souto JC, Martinez E, Roca M, Mateo J, Pujol J, Gonzalez D, Fontcuberta J: Prothrombotic state and signs of endothelial lesion in plasma of patients with inflammatory bowel disease. Dig Dis Sci 1995, 40:1883-1889
52. Chamouard P, Grunebaum L, Wiesel ML, Frey PL, Wittersheim C, Sapin R, Baumann R, Cazenave JP: Prothrombin fragment 1 + 2 and thrombin-antithrombin III complex as markers of activation of blood coagulation in inflammatory bowel diseases. Eur J Gastroenterol Hepatol 1995, 7:1183-1188
53. Thompson NP, Wakefield AJ, Pounder RE: Inherited disorders of coagulation appear to protect against inflammatory bowel disease. Gastroenterology 1995, 108:1011-1015
54. Lee LC, Spittell JA Jr, Sauer WG, Owen CA Jr, Thompson JH Jr: Hypercoagulability associated with chronic ulcerative colitis: changes in blood coagulation factors. Gastroenterology 1968, 54:76-85
55. Hudson M, Chitolie A, Hutton RA, Smith MS, Pounder RE, Wakefield AJ: Thrombotic vascular risk factors in inflammatory bowel disease. Gut 1996, 38:733-737
56. Sankey EA, Dhillon AP, Anthony A, Wakefield AJ, Sim R, More L, Hudson M, Sawyerr AM, Pounder RE: Early mucosal changes in Crohn's disease. Gut 1993, 34:375-381
57. Anthoni C, Russell J, Wood KC, Stokes KY, Vowinkel T, Kirchhofer D, Granger DN: Tissue factor: a mediator of inflammatory cell recruitment, tissue injury, and thrombus formation in experimental colitis. J Exp Med 2007, 204:1595-1601
58. Faioni EM, Ferrero S, Fontana G, Gianelli U, Ciulla MM, Vecchi M, Saibeni S, Biguzzi E, Cordani N, Franchi F, Bosari S, Cattaneo M: Expression of endothelial protein C receptor and thrombomodulin in the intestinal tissue of patients with inflammatory bowel disease. Crit Care Med 2004, 32:S266-S270
59. Scaldaferri F, Sans M, Vetrano S, Graziani C, de Cristofaro R, Gerlitz B, Repici A, Arena V, Malesci A, Panes J, Grinnell BW, Danese S: Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease. J Clin Invest 2007, 117:1951-1960
60. Hatoum OA, Binion DG, Gutterman DD: Paradox of simultaneous intestinal ischaemia and hyperaemia in inflammatory bowel disease. Eur J Clin Invest 2005, 35:599-609
61. McGarrity TJ, Manasse JS, Koch KL, Weidner WA: Crohn's disease and massive lower gastrointestinal bleeding: angiographic appearance and two case reports. Am J Gastroenterol 1987, 82:1096-1099
62. Mellor JA, Chandler GN, Chapman AH, Irving HC: Massive gastrointestinal bleeding in Crohn's disease: successful control by intraarterial vasopressin infusion. Gut 1982, 23:872-874
63. Erikson U, Fagerberg S, Krause U, Olding L: Angiographic studies in Crohn's disease and ulcerative colitis. Am J Roentgenol Radium Ther Nucl Med 1970, 110:385-392
64. Brahme F: Mesenteric angiography in regional enterocolitis. Radiology 1966, 87:1037-1042
65. Angerson WJ, Allison MC, Baxter JN, Russell RI: Neoterminal ileal blood flow after ileocolonic resection for Crohn's disease. Gut 1993, 34:1531-1534
66. Guslandi M, Polli D, Sorghi M, Tittobello A: Rectal blood flow in ulcerative colitis. Am J Gastroenterol 1995, 90:579-580
67. Hulten L, Lindhagen J, Lundgren O, Fasth S, Ahren C: Regional intestinal blood flow in ulcerative colitis and Crohn's disease. Gastroenterology 1977, 72:388-396
68. Appleyard CB, Alvarez A, Percy WH: Temporal changes in colonic vascular architecture and inflammatory mediator levels in animal models of colitis. Dig Dis Sci 2002, 47:2007-2014
69. Kruschewski M, Foitzik T, Perez-Canto A, Hubotter A, Buhr HJ: Changes of colonic mucosal microcirculation and histology in two colitis models: an experimental study using intravital microscopy and a new histological scoring system. Dig Dis Sci 2001, 46:2336-2343
70. McLaren WJ, Anikijenko P, Thomas SG, Delaney PM, King RG: In vivo detection of morphological and microvascular changes of the colon in association with colitis using fiberoptic confocal imaging (FOCI). Dig Dis Sci 2002, 47:2424-2433
71. Foitzik T, Kruschewski M, Kroesen A, Buhr HJ: Does microcirculation play a role in the pathogenesis of inflammatory bowel diseases? Answers from intravital microscopic studies in animal models. Int J Colorectal Dis 1999, 14:29-34
72. Appleyard CB, Williams JL, Hathaway CA, Percy WH: Temporal patterns of colonic blood flow and tissue damage in an animal model of colitis. Dig Dis Sci 1999, 44:431-438
73. Carr N: Microvascular disease in the human large bowel. Gut 1996, 39:889-890
74. Ravnic DJ, Konerding MA, Tsuda A, Huss HT, Wolloscheck T, Pratt JP, Mentzer SJ: Structural adaptations in the murine colon microcirculation associated with hapten-induced inflammation. Gut 2007, 56:518-523
75. Hatoum OA, Binion DG, Otterson MF, Gutterman DD: Acquired microvascular dysfunction in inflammatory bowel disease: loss of nitric oxide-mediated vasodilation. Gastroenterology 2003, 125:58-69
76. Mori M, Stokes KY, Vowinkel T, Watanabe N, Elrod JW, Harris NR, Lefer DJ, Hibi T, Granger DN: Colonic blood flow responses in experimental colitis: time course and underlying mechanisms. Am J Physiol Gastrointest Liver Physiol 2005, 289:G1024-G1029
77. Wakefield AJ, Sankey EA, Dhillon AP, Sawyerr AM, More L, Sim R, Pittilo RM, Rowles PM, Hudson M, Lewis AA: Granulomatous vasculitis in Crohn's disease. Gastroenterology 1991, 100:1279-1287
78. Carmeliet P: Angiogenesis in health and disease. Nat Med 2003, 9:653-660
79. Koutroubakis IE, Tsiolakidou G, Karmiris K, Kouroumalis EA: Role of angiogenesis in inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:515-523
80. Risau W: Mechanisms of angiogenesis. Nature 1997, 386:671-674
81. Scapini P, Nesi L, Morini M, Tanghetti E, Belleri M, Noonan D, Presta M, Albini A, Cassatella MA: Generation of biologically active angiostatin kringle 1-3 by activated human neutrophils. J Immunol 2002, 168:5798-5804
82. Taylor PC, Sivakumar B: Hypoxia and angiogenesis in rheumatoid arthritis. Curr Opin Rheumatol 2005, 17:293-298
83. Hatton MW, Southward SM, Legault KJ, Ross BL, Clarke BJ, Bajzar L, Blajchman MA, Singh G, Richardson M: Fibrinogen catabolism within the procoagulant VX-2 tumor of rabbit lung in vivo: effluxing fibrin(ogen) fragments contain antiangiogenic activity. J Lab Clin Med 2004, 143:241-254
84. Collin-Osdoby P, Rothe L, Bekker S, Anderson F, Huang Y, Osdoby P: Basic fibroblast growth factor stimulates osteoclast recruitment, development, and bone pit resorption in association with angiogenesis in vivo on the chick chorioallantoic membrane and activates isolated avian osteoclast resorption in vitro. J Bone Miner Res 2002, 17:1859-1871
85. Crivellato E, Ribatti D: Involvement of mast cells in angiogenesis and chronic inflammation. Curr Drug Targets Inflamm Allergy 2005, 4:9-11
86. Milkiewicz M, Brown MD, Egginton S, Hudlicka O: Association between shear stress, angiogenesis, and VEGF in skeletal muscles in vivo. Microcirculation 2001, 8:229-241
87. Cullen JP, Sayeed S, Sawai RS, Theodorakis NG, Cahill PA, Sitzmann JV, Redmond EM: Pulsatile flow-induced angiogenesis: role of G(i) subunits. Arterioscler Thromb Vasc Biol 2002, 22:1610-1616
88. Carmeliet P: Mechanisms of angiogenesis and arteriogenesis. Nat Med 2000, 6:389-395
89. Majno G: Chronic inflammation: links with angiogenesis and wound healing. Am J Pathol 1998, 153:1035-1039
90. Vainer B, Nielsen OH: Changed colonic profile of P-selectin, platelet-endothelial cell adhesion molecule-1 (PECAM-1), intercellular adhesion molecule-1 (ICAM-1). ICAM-2, and ICAM-3 in inflammatory bowel disease. Clin Exp Immunol 2000, 121:242-247
91. Vainer B, Sorensen S, Nielsen OH, Horn T: Subcellular localization of intercellular adhesion molecule-1 in colonic mucosa in ulcerative colitis. Ultrastruct Pathol 2002, 26:113-121
92. Danese S, Semeraro S, Marini M, Roberto I, Armuzzi A, Papa A, Gasbarrini A: Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation. Dig Liver Dis 2005, 37:811-818
93. Eliceiri BP, Cheresh DA: Role of alpha v integrins during angiogenesis. Cancer J 2000, 6 (Suppl 3):S245-S249
94. Danese S, Scaldaferri F, Vetrano S, Stefanelli T, Graziani C, Repici A, Ricci R, Sgambato A, Straface G, Malesci A, Fiocchi C, Rutella S: Critical role of the CD40-CD40-ligand pathway in regulating mucosal inflammation-driven angiogenesis in inflammatory bowel disease. Gut 2007, 56:1248-1256
95. Chidlow JH Jr, Langston W, Greer JJ, Ostanin D, Abdelbaqi M, Houghton J, Senthilkumar A, Shukla D, Mazar AP, Grisham MB, Kevil CG: Differential angiogenic regulation of experimental colitis. Am J Pathol 2006, 169:2014-2030
96. Ortega-Cava CF, Ishihara S, Kawashima K, Rumi MA, Kazumori H, Adachi K, Kinoshita Y: Hepatocyte growth factor expression in dextran sodium sulfate-induced colitis in rats. Dig Dis Sci 2002, 47:2275-2285
97. Danese S, Sans M, de la Motte C, Graziani C, West G, Phillips MH, Pola R, Rutella S, Willis J, Gasbarrini A, Fiocchi C: Angiogenesis as a novel component of inflammatory bowel disease pathogenesis. Gastroenterology 2006, 130:2060-2073
98. Bardin N, Reumaux D, Geboes K, Colombel JF, Blot-Chabaud M, Sampol J, Duthilleul P, Dignat-George F: Increased expression of CD146, a new marker of the endothelial junction in active inflammatory bowel disease. Inflamm Bowel Dis 2006, 12:16-21
99. Saito S, Tsuno NH, Sunami E, Hori N, Kitayama J, Kazama S, Okaji Y, Kawai K, Kanazawa T, Watanabe T, Shibata Y, Nagawa H: Expression of platelet-derived endothelial cell growth factor in inflammatory bowel disease. J Gastroenterol 2003, 38:229-237
100. Kanazawa S, Tsunoda T, Onuma E, Majima T, Kagiyama M, Kikuchi K: VEGF, basic-FGF, and TGF-beta in Crohn's disease and ulcerative colitis: a novel mechanism of chronic intestinal inflammation. Am J Gastroenterol 2001, 96:822-828
101. Bousvaros A, Zurakowski D, Fishman SJ, Keough K, Law T, Sun C, Leichtner AM: Serum basic fibroblast growth factor in pediatric Crohn's disease. Implications for wound healing. Dig Dis Sci 1997, 42:378-386
102. Koutroubakis IE, Xidakis C, Karmiris K, Sfiridaki A, Kandidaki E, Kouroumalis EA: Potential role of soluble angiopoietin-2 and Tie-2 in patients with inflammatory bowel disease. Eur J Clin Invest 2006, 36:127-132
103. Danese S, Sans M, Scaldaferri F, Sgambato A, Rutella S, Cittadini A, Pique JM, Panes J, Katz JA, Gasbarrini A, Fiocchi C: TNF-alpha blockade down-regulates the CD40/CD40L pathway in the mucosal microcirculation: a novel anti-inflammatory mechanism of infliximab in Crohn's disease. J Immunol 2006, 176:2617-2624
104. Goebel S, Huang M, Davis WC, Jennings M, Siahaan TJ, Alexander JS, Kevil CG: VEGF-A stimulation of leukocyte adhesion to colonic microvascular endothelium: implications for inflammatory bowel disease. Am J Physiol Gastrointest Liver Physiol 2006, 290:G648-G654
105. Hatoum OA, Heidemann J, Binion DG: The intestinal microvasculature as a therapeutic target in inflammatory bowel disease. Ann NY Acad Sci 2006, 1072:78-97